NO905106L - Fremgangsmaate for fremstilling av et farmasoeytisk preparat - Google Patents

Fremgangsmaate for fremstilling av et farmasoeytisk preparat

Info

Publication number
NO905106L
NO905106L NO90905106A NO905106A NO905106L NO 905106 L NO905106 L NO 905106L NO 90905106 A NO90905106 A NO 90905106A NO 905106 A NO905106 A NO 905106A NO 905106 L NO905106 L NO 905106L
Authority
NO
Norway
Prior art keywords
weight
pharmaceutical preparation
denotes
preparing
procedure
Prior art date
Application number
NO90905106A
Other languages
English (en)
Other versions
NO180475B (no
NO180475C (no
NO905106D0 (no
Inventor
Walter Fries
Original Assignee
Nachf Heinrich Mact
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nachf Heinrich Mact filed Critical Nachf Heinrich Mact
Publication of NO905106D0 publication Critical patent/NO905106D0/no
Publication of NO905106L publication Critical patent/NO905106L/no
Publication of NO180475B publication Critical patent/NO180475B/no
Publication of NO180475C publication Critical patent/NO180475C/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/22—Heterocyclic compounds, e.g. ascorbic acid, tocopherol or pyrrolidones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Engineering & Computer Science (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Plural Heterocyclic Compounds (AREA)
NO905106A 1989-11-29 1990-11-26 Fremgangsmåte for fremstilling av et farmasöytisk preparat NO180475C (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE3939492A DE3939492A1 (de) 1989-11-29 1989-11-29 Pharmazeutische zubereitungen

Publications (4)

Publication Number Publication Date
NO905106D0 NO905106D0 (no) 1990-11-26
NO905106L true NO905106L (no) 1991-05-30
NO180475B NO180475B (no) 1997-01-20
NO180475C NO180475C (no) 1997-04-30

Family

ID=6394433

Family Applications (1)

Application Number Title Priority Date Filing Date
NO905106A NO180475C (no) 1989-11-29 1990-11-26 Fremgangsmåte for fremstilling av et farmasöytisk preparat

Country Status (29)

Country Link
US (1) US5118698A (no)
EP (1) EP0430149B1 (no)
JP (1) JPH0660097B2 (no)
KR (1) KR940000066B1 (no)
CN (1) CN1035357C (no)
AT (1) ATE102051T1 (no)
AU (1) AU626480B2 (no)
BR (1) BR9006025A (no)
CA (1) CA2030911C (no)
CY (1) CY1970A (no)
CZ (1) CZ282898B6 (no)
DE (2) DE3939492A1 (no)
DK (1) DK0430149T3 (no)
EG (1) EG19557A (no)
ES (1) ES2062271T3 (no)
FI (1) FI103713B (no)
HK (1) HK216896A (no)
HU (1) HU220867B1 (no)
IE (1) IE64672B1 (no)
IL (1) IL96450A (no)
MX (1) MX23518A (no)
MY (1) MY104540A (no)
NO (1) NO180475C (no)
NZ (1) NZ236255A (no)
PT (1) PT96003B (no)
RU (1) RU2038080C1 (no)
SK (1) SK280599B6 (no)
YU (1) YU227290A (no)
ZA (1) ZA909549B (no)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5397771A (en) * 1990-05-10 1995-03-14 Bechgaard International Research And Development A/S Pharmaceutical preparation
AU7880991A (en) * 1990-05-10 1991-11-27 Novo Nordisk A/S A pharmaceutical preparation containing n-glycofurols and n-ethylene glycols
JP3485540B2 (ja) * 2000-12-28 2004-01-13 新日本製鐵株式会社 低騒音トランス
ES2331058T3 (es) * 2001-02-28 2009-12-21 Intervet International Bv Emulsiones de agua en aceite inyectables.
AU2003210517A1 (en) 2002-02-04 2003-09-02 Elan Pharma International, Ltd. Drug nanoparticles with lysozyme surface stabiliser
EP1551457A1 (en) * 2002-07-16 2005-07-13 Elan Pharma International Limited Liquid dosage compositions of stable nanoparticulate active agents

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1196284A (en) * 1982-05-28 1985-11-05 Joshua Oduro-Yeboah Pharmaceutical formulations
GR79307B (no) * 1982-06-09 1984-10-22 Pfizer
AU4882685A (en) * 1984-10-19 1986-04-24 Schering Corporation 1,3-bis(1h-1,2,4-triazol-1-yl)-2-fluoro-2-(2,4- difluorophenyl) propane

Also Published As

Publication number Publication date
CA2030911A1 (en) 1991-05-30
SK595390A3 (en) 2000-04-10
FI905814A0 (fi) 1990-11-26
DE69007029D1 (de) 1994-04-07
FI103713B1 (fi) 1999-08-31
DE69007029T2 (de) 1994-06-09
PT96003A (pt) 1991-09-13
DK0430149T3 (da) 1994-03-28
NO180475B (no) 1997-01-20
CN1052046A (zh) 1991-06-12
EP0430149A2 (en) 1991-06-05
BR9006025A (pt) 1991-09-24
CY1970A (en) 1997-09-05
NZ236255A (en) 1992-02-25
IE904282A1 (en) 1991-06-05
DE3939492A1 (de) 1991-06-06
ZA909549B (en) 1992-06-24
IL96450A (en) 1994-10-21
US5118698A (en) 1992-06-02
HUT57039A (en) 1991-11-28
SK280599B6 (sk) 2000-04-10
ATE102051T1 (de) 1994-03-15
IE64672B1 (en) 1995-08-23
JPH0660097B2 (ja) 1994-08-10
CN1035357C (zh) 1997-07-09
HU220867B1 (en) 2002-06-29
RU2038080C1 (ru) 1995-06-27
FI905814A (fi) 1991-05-30
EG19557A (en) 1997-08-31
ES2062271T3 (es) 1994-12-16
NO180475C (no) 1997-04-30
NO905106D0 (no) 1990-11-26
JPH03176421A (ja) 1991-07-31
YU227290A (sh) 1993-10-20
CZ282898B6 (cs) 1997-11-12
EP0430149A3 (en) 1991-09-25
KR940000066B1 (ko) 1994-01-05
EP0430149B1 (en) 1994-03-02
HK216896A (en) 1996-12-27
AU6706590A (en) 1991-08-08
FI103713B (fi) 1999-08-31
MX23518A (es) 1993-04-01
KR910009286A (ko) 1991-06-28
CZ595390A3 (en) 1997-06-11
AU626480B2 (en) 1992-07-30
MY104540A (en) 1994-04-30
PT96003B (pt) 1998-01-30
CA2030911C (en) 1995-02-07

Similar Documents

Publication Publication Date Title
ATE79376T1 (de) Dithioacetal-verbindungen, verfahren zu deren herstellung und diese enthaltende pharmazeutische zusammensetzungen.
NO813359L (no) Fremgangsmaate for fremstilling av 1,2,3,4-tetrahydro-isokinolin-3-karboksylsyre-derivater
ATE68180T1 (de) Morpholinoethylester von mycophenolsaeure und ihre derivate, ihre herstellung und verwendung in pharmazeutische zusammensetzungen.
SE7906472L (sv) Nya 3-(aminoetyl)-fenol-derivat och salter derav, sett for framstellning och anvendning derav sasom lekemedel samt farmaceutiska kompositioner innehallande dessa foreningar
FR2669927B1 (fr) Nouveaux derives de guanidine, leur procede de preparation et les compositions pharmaceutiques qui les contiennent.
ATE109770T1 (de) Derivate der coffeinsäure und pharmazeutische zusammensetzungen, die sie enthalten.
FI881816A (fi) Nya bicykliska foereningar, foerfarande foer deras framstaellning och dessa innehaollande farmaceutiska blandningar.
NO905106L (no) Fremgangsmaate for fremstilling av et farmasoeytisk preparat
DK451389D0 (da) 2-substituerede 4,5-diaryl-thioimidazoler samt farmaceutisk praeparat indeholdende saadanne forbindelser
ATE123487T1 (de) Derivate der kaffeinsäure und sie enthaltende pharmazeutische zusammensetzungen.
SE8505369L (sv) Nya tienopyridinderivat, ett forfarande for framstellning derav och terapeutiska kompositioner innehallande dem
SE8000699L (sv) Nya kinazolinderivat jemte sett for deras framstellning och farmaceutiska beredningar innehallande dem
SE9402596L (sv) Karboximetylidencykloheptimidazolderivat, förfarande för deras framställning och terapeutiska medel innehållande dessa föreningar
SE8100122L (sv) Nya 2-aminometyl-6-halo-fenoler, framstellning derav och farmaceutiska kompositioner innehallande dessa
DE69016378D1 (de) Substituierte Benzothiazolinone, ihre Herstellung und sie enthaltende pharmazeutische Zusammenstellungen.
RU92016560A (ru) Замещенные бензоимидазолы, фармацевтическая композиция, способ ингибирования или лечения и способ их получения и применение